Spirit Live

The Spirit of giving back

Spirit Group is very pleased to announce that our nominated charity for 2018/19 will be the Seashell Trust, based in Cheadle Hulme, very near our Didsbury offices! Founded in 1873 as a school for deaf children, Seashell Trust now offers specialist programmes of care for children and young people with complex learning difficulties in their…Read more »

Spirit Group is very pleased to announce that our nominated charity for 2018/19 will be the Seashell Trust, based in Cheadle Hulme, very near our Didsbury offices!

Founded in 1873 as a school for deaf children, Seashell Trust now offers specialist programmes of care for children and young people with complex learning difficulties in their school, college and residential care homes.

Spirit Group teams from our Didsbury and Alderley Park offices will be getting stuck in at Seashell volunteer days and organising all kinds of activities to raise what we can for this wonderful cause. Some of the things we hope to get involved in are:

  • Administration
  • Befriending
  • Classroom support
  • Events
  • Gardening
  • Swimming and sport
  • Therapy

The funds we raise will go towards activity trips, assistive technology to help with communication and development, family events to support the parents and siblings of Seashell’s children and young people, and sports and therapy equipment.

We look forward to sharing our fund-raising and volunteering experiences that will all go towards improving the learning outcomes and quality of life of Seashell’s children and young people.

If you would like to learn more about Seashell and the work they do, please visit them at:

http://www.seashelltrust.org.uk/

https://www.facebook.com/Seashelltrust

https://twitter.com/seashelltrust

Share

TwitterFacebookLinkedInGoogle+Email

Spirit Group at EULAR 2018

This year’s European League Against Rheumatism (EULAR) congress was a busy one indeed! A record breaking >5000 abstract submissions and 32 industry-supported symposia, many running simultaneously, reflecting the highly-competitive nature of the meeting and underscoring the need for communications and content with a difference. Key front page EULAR Congress News themes included: Patient engagement with…Read more »

This year’s European League Against Rheumatism (EULAR) congress was a busy one indeed! A record breaking >5000 abstract submissions and 32 industry-supported symposia, many running simultaneously, reflecting the highly-competitive nature of the meeting and underscoring the need for communications and content with a difference.

Key front page EULAR Congress News themes included:

Patient engagement with their treatment and their disease
Enabling and encouraging patients to be more than passive participants in their own care was a very hot topic. Dr Yeliz Prior, PhD, Director of postgraduate research at the School of Health Sciences at the University of Salford in Manchester, UK noted that “We know that patient information and education have been shown to improve pain, self-efficacy and overall quality of life in people with musculoskeletal conditions (MSCs)”.  She added that “Informed patients are better equipped to distinguish and manage the symptoms of MSCs, use treatments effectively, identify and access [the] appropriate health and social care services they need, manage work and develop better coping strategies to deal with the negative psychological impact of their own conditions, such as stress, anxiety and depression”.

The ‘Don’t Delay, Connect Today’ campaign
The theme of patient engagement was also reflected in EULARs ‘Don’t Delay, Connect Today’ campaign. The campaign is now in its second year and aims to raise awareness of how important early diagnosis, and early treatment where indicated, is in preventing further damage for people with rheumatic and musculoskeletal diseases (RMDs). Prof. Gerd R. Burmester (Past President of EULAR and Professor of medicine at Berlin’s Charité University Clinic) noted that by encouraging people to work together, positive steps can be taken to improve the lives of those living with RMDs. This is particularly significant as awareness of the importance of early diagnosis is limited amongst the general public, in people with RMDs, and even among many doctors and health professionals in rheumatology.

Biosimilar use
The importance of keeping the patient at the centre of the decision to switch from an originator biologic to a biosimilar was also at the forefront of many presentations and discussions. There was a call for more randomised controlled trials on the safety of multiple switching, and discussion about the vital role of pharmacovigilance in confirming the safety of all biologics on a long-term basis.

We’re looking forward to next year’s agenda already!

Share

TwitterFacebookLinkedInGoogle+Email

Spirit Group at the 23rd congress of the European Hematology Association

This weekend Spirit Group were in Stockholm, attending the 23rd congress of the European Hematology Association, one of the largest hematology events of the year. Hot topics this year included: The increasing use of biomarkers in the treatment of hematological malignancies. In addition to their prognostic value, biomarkers are increasingly being used to guide treatment…Read more »

This weekend Spirit Group were in Stockholm, attending the 23rd congress of the European Hematology Association, one of the largest hematology events of the year.

Hot topics this year included:

  • The increasing use of biomarkers in the treatment of hematological malignancies. In addition to their prognostic value, biomarkers are increasingly being used to guide treatment by identifying patients likely to respond to particular therapies or those at increased risk of adverse events.
  • The move away from chemotherapies towards using combinations of targeted therapies to treat indolent Non-Hodgkin lymphoma. With a plethora of targeted therapies either approved or under investigation for use in these indications, including anti-CD20 monoclonal antibodies and B-cell receptor signaling inhibitors, the key challenge will be finding out the optimal way to combine these powerful agents.

This years’ presidential symposium (a session covering abstracts of particularly important scientific interest) included data from two studies involving rituximab, an anti-CD20 monoclonal antibody, in non-Hodgkin lymphoma.

Presented first were data from the Phase 3 CLL11 study, which was designed to compare the efficacy and safety of rituximab and obinutuzumab (a glycoengineered anti-CD20 monoclonal antibody), both in combination with the chemotherapy agent chlorambucil, in patients with chronic lymphocytic leukemia. In this final analysis of the study, obinutuzumab was found to significantly prolong progression-free survival, time to next treatment and overall survival compared with rituximab; however, caution must be exercised as obinutuzumab was associated with greater toxicity than rituximab.

Also presented in this session were data from the Phase 3 RELEVANCE study, which was designed to compare the efficacy and safety of rituximab combined with either chemotherapy (current standard of care) or the immunomodulatory agent lenalidomide, in patients with follicular lymphoma. The two treatments were found to have comparable efficacy, but differences in their safety profiles, suggesting that rituximab plus lenalidomide may be a treatment option for certain patients at risk of toxicities associated with the current standard of care.

In summary, a wealth of interesting and exciting research was presented across the 4-day congress in both oral and poster format. We can’t wait to see the latest data at next year’s congress in Amsterdam; we hope to see you there!

Share

TwitterFacebookLinkedInGoogle+Email

The Spirit Group team supporting #MedComms Day

The Spirit Group team are happy to have been involved with #MedComms Day on 6th June – celebrating the great work across our offices/remote teams on projects being delivered around the globe.

The Spirit Group team are happy to have been involved with #MedComms Day on 6th June – celebrating the great work across our offices/remote teams on projects being delivered around the globe.

Share

TwitterFacebookLinkedInGoogle+Email

Spirit at eyeforpharma Barcelona, 13-15 March 2018

A team from Spirit Group attended eyeforpharma Medical Affairs in Barcelona to participate in lively discussions surrounding the evolution of Medical Affairs. One of the hot topics this year was Maintaining MSL authenticity under commercial pressures, with both plenary sessions and a Spirit-facilitated roundtable being dedicated exclusively to this subject. Key themes feeding into discussions on…Read more »

A team from Spirit Group attended eyeforpharma Medical Affairs in Barcelona to participate in lively discussions surrounding the evolution of Medical Affairs. One of the hot topics this year was Maintaining MSL authenticity under commercial pressures, with both plenary sessions and a Spirit-facilitated roundtable being dedicated exclusively to this subject.

Key themes feeding into discussions on maintaining MSL authenticity – during the plenary, the roundtable and a pre-congress survey of key Medical stakeholders – are captured in our eyeforpharma Barcelona Medical Affairs Newsletter.

Please click here to request a copy or to discuss any aspect of the evolution of the Medical function further.

 

Share

TwitterFacebookLinkedInGoogle+Email

Spirit at the European ISMPP meeting in London, 23-24 January 2018

Increased data transparency, drives for open access as standard, and progress towards greater patient involvement in publications were the key themes at the 2018 European ISMPP meeting. The Spirit team were represented onsite by Amanda Pedder, Medical Writer and Ben Caldwell, Scientific Director. Exciting news came courtesy of Shire, who have committed to submit all…Read more »

Increased data transparency, drives for open access as standard, and progress towards greater patient involvement in publications were the key themes at the 2018 European ISMPP meeting. The Spirit team were represented onsite by Amanda Pedder, Medical Writer and Ben Caldwell, Scientific Director. Exciting news came courtesy of Shire, who have committed to submit all Shire-supported research manuscripts to journals offering open access. Their press release on the topic is available here: https://www.shire.com/en/newsroom/2018/january/xajhds

Over 300 publication experts attended the meeting; pharma/biotech staff represented almost one-third of the audience, and medical communications agencies were the majority of the remainder. The meeting was extremely stimulating, with a great deal of exciting research and debate presented both in the plenary sessions and in poster form. We’re looking forward to the next meeting already!

Share

TwitterFacebookLinkedInGoogle+Email

Getting in the festive Spirit!

Our Didsbury team made the most of festivities at Towers Business Park last week. A Christmas-inspired tepee stood proudly in the Piazza and was host to a Christmas wreath-making workshop that a few of the team took part in. Can you guess which member of our team made the winning wreath and received a whopping…Read more »

Our Didsbury team made the most of festivities at Towers Business Park last week. A Christmas-inspired tepee stood proudly in the Piazza and was host to a Christmas wreath-making workshop that a few of the team took part in.

Can you guess which member of our team made the winning wreath and received a whopping £100 prize? Tweet us @spirit_med and all will be revealed!

(Left to right: Fiona, Sarah M, Eve, Jess)

For others it was simply a chance to embrace the Christmas spirit and enjoy carol singers, mulled wine and hot chocolate!

Today we are supporting Save the Children Christmas Jumper Day. Teams across both sites, as well as our remote workers, have all made an effort in support of this worthy cause – including our most historically Christmas-jumper resistant team members and Pedro the guinea pig!

 

Share

TwitterFacebookLinkedInGoogle+Email

High Spirits at our Spooky Halloween Fundraiser

Our team put together a superb Halloween fundraiser yesterday to raise money for the Genie Family Centre, a registered charity that provides support for deaf people and their families. Transforming our office … and our colleagues too! … we partook in a delicious bake sale, pumpkin carving and ‘guess how many spooky sweets in the…Read more »

Our team put together a superb Halloween fundraiser yesterday to raise money for the Genie Family Centre, a registered charity that provides support for deaf people and their families. Transforming our office … and our colleagues too! … we partook in a delicious bake sale, pumpkin carving and ‘guess how many spooky sweets in the jar’ competitions, to show our support for this worthy charity who have provided amazing support to our colleague and friend, Holly.

 

A fantastic day was had by all, and we managed to raise an impressive £365! Well done team 😊

 

Share

TwitterFacebookLinkedInGoogle+Email

Collaboration & Crystals!

We had a fantastic Company Meeting last week at the Great John Street Hotel in Manchester! Pioneers in Science connected to Manchester was the theme behind our teams (Lovell, Dalton, Rutherford, Kilburn) which set the scene for a day centred around innovative thinking to address common challenges in the Medical Communications environment. With several new…Read more »

We had a fantastic Company Meeting last week at the Great John Street Hotel in Manchester!

Pioneers in Science connected to Manchester was the theme behind our teams (Lovell, Dalton, Rutherford, Kilburn) which set the scene for a day centred around innovative thinking to address common challenges in the Medical Communications environment.

With several new starters in our midst as we continue to grow, we also capitalised on a prime opportunity to share insight and opinion to help shape the future of Spirit.

Not satisfied with just the fantastic outputs of this extremely productive meeting, we then faced the ultimate challenge… testing our skill, physical and mental abilities in the Crystal Maze – ‘Start the fans please!’

Well done to Team Dalton who came top of the leader board!, although all teams partook in a well-deserved celebratory drinkie…or three 😊

 

Share

TwitterFacebookLinkedInGoogle+Email

Never a dull moment during congress season!

Our Client Services and Medical & Scientific Services teams are extremely busy co-ordinating a myriad of activities around three major congresses this month. Through fantastic teamwork, we have successfully navigated … – The challenge of obtaining over the summer holidays all author approvals required to ensure finalisation of oral presentations, print sign off and shipping…Read more »

Our Client Services and Medical & Scientific Services teams are extremely busy co-ordinating a myriad of activities around three major congresses this month. Through fantastic teamwork, we have successfully navigated …

– The challenge of obtaining over the summer holidays all author approvals required to ensure finalisation of oral presentations, print sign off and shipping of multiple postersincluding a winner of the Best Poster Award at ESMO!

– Working closely with authors and journal publishers to achieve hot-off-the-press data release in parallel with the relevant congress

– Co-ordination of a series of webinars delivering up-to-date data and clinical developments, broadcast simultaneously in multiple languages, with live question and answer functionality

– Juggling of multiple components to deliver cutting-edge, innovatively-themed symposia employing novel formats and the latest technologies

– Delivery of highly interactive content and high-spec animations for exhibition booths

– And, of course… smooth handling of all unforeseen circumstance, such as the need for last-minute filming of keynote speakers who can’t make it to the congress at the final hour.

In between all this, we are still finding time to fit in holidays of our own, and participate in bake offs and crowd surfing!

 

 

 

 

 

Share

TwitterFacebookLinkedInGoogle+Email